[Orthotopic liver transplantation and hepatocellular carcinoma].
Nineteen orthotopic liver transplantations (OLT) were performed in patients with hepatocellular carcinoma, between March 1988 and December 1990, in our Department. Thirteen patients (68.4%), 10 men and 3 women, mean age 48.2 +/- 2.8 years, were clear cut neoplastic disease, six patients (31.6%), 4 men and 2 women, mean age 48.6 +/- 4.2 years, were incidental tumors. Three years survival rate was 20% in clear cut neoplastic diseases (4 patients died for neoplastic recurrence) and 66% in incidental tumors. Our results demonstrate that liver transplantation for hepatobiliary malignancy is still justified, patient selection is important in predicting outcome.
Gugenheim
J
J
Unità Trapianti d'Organo, Centro Ospedaliero Universitario, St. Roch, Nizza, Francia.
Crafa
F
F
Iovine
L
L
Fabiani
P
P
Militerno
G
G
Spampatti
G
G
Goubaux
B
B
Mouiel
J
J
D000206:Actuarial Analysis; D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D004621:Embolization, Therapeutic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007430:Intraoperative Care; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011300:Preoperative Care
Trapianto ortotopico di fegato e carcinoma epatocellulare.